These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 26633639)
1. Promise and pitfalls of pre-exposure prophylaxis for female sex workers. Cowan FM; Delany-Moretlwe S Curr Opin HIV AIDS; 2016 Jan; 11(1):27-34. PubMed ID: 26633639 [TBL] [Abstract][Full Text] [Related]
2. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice. Haberer JE Curr Opin HIV AIDS; 2016 Jan; 11(1):10-7. PubMed ID: 26633638 [TBL] [Abstract][Full Text] [Related]
3. The preexposure prophylaxis revolution; from clinical trials to programmatic implementation. Mugo NR; Ngure K; Kiragu M; Irungu E; Kilonzo N Curr Opin HIV AIDS; 2016 Jan; 11(1):80-6. PubMed ID: 26575147 [TBL] [Abstract][Full Text] [Related]
4. What does preexposure prophylaxis mean for treatment; what does treatment mean for preexposure prophylaxis? Venter WD Curr Opin HIV AIDS; 2016 Jan; 11(1):35-40. PubMed ID: 26545265 [TBL] [Abstract][Full Text] [Related]
5. Planning for HIV preexposure prophylaxis introduction: lessons learned from contraception. Delany-Moretlwe S; Mullick S; Eakle R; Rees H Curr Opin HIV AIDS; 2016 Jan; 11(1):87-93. PubMed ID: 26575146 [TBL] [Abstract][Full Text] [Related]
6. Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women. Thomson KA; Baeten JM; Mugo NR; Bekker LG; Celum CL; Heffron R Curr Opin HIV AIDS; 2016 Jan; 11(1):18-26. PubMed ID: 26417954 [TBL] [Abstract][Full Text] [Related]
7. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project. Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H; PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256 [TBL] [Abstract][Full Text] [Related]
8. The preexposure prophylaxis revolution: from clinical trials to routine practice: implementation view from the USA. Elion R; Coleman M Curr Opin HIV AIDS; 2016 Jan; 11(1):67-73. PubMed ID: 26599165 [TBL] [Abstract][Full Text] [Related]
10. The European preexposure prophylaxis revolution. Cairns G; McCormack S; Molina JM Curr Opin HIV AIDS; 2016 Jan; 11(1):74-9. PubMed ID: 26599164 [TBL] [Abstract][Full Text] [Related]
11. Statistical issues in trials of preexposure prophylaxis. Dunn DT; Glidden DV Curr Opin HIV AIDS; 2016 Jan; 11(1):116-21. PubMed ID: 26545264 [TBL] [Abstract][Full Text] [Related]
12. The role of healthcare providers in the roll out of preexposure prophylaxis. Krakower DS; Mayer KH Curr Opin HIV AIDS; 2016 Jan; 11(1):41-8. PubMed ID: 26417953 [TBL] [Abstract][Full Text] [Related]
13. "Whatever is in the ARVs, is Also in the PrEP" Challenges Associated With Oral Pre-exposure Prophylaxis Use Among Female Sex Workers in South Africa. Makhakhe NF; Sliep Y; Meyer-Weitz A Front Public Health; 2022; 10():691729. PubMed ID: 35784260 [TBL] [Abstract][Full Text] [Related]
14. Welcome to the preexposure prophylaxis revolution. Baeten J; McCormack S Curr Opin HIV AIDS; 2016 Jan; 11(1):1-2. PubMed ID: 26633637 [No Abstract] [Full Text] [Related]
15. What people want from sex and preexposure prophylaxis. Grant RM; Koester KA Curr Opin HIV AIDS; 2016 Jan; 11(1):3-9. PubMed ID: 26569183 [TBL] [Abstract][Full Text] [Related]
16. Uptake, retention, and outcomes in a demonstration project of pre-exposure prophylaxis among female sex workers in public health centers in Senegal. Sarr M; Gueye D; Mboup A; Diouf O; Bao MDB; Ndiaye AJ; Ndiaye BP; Hawes SE; Tousset E; Diallo A; Jones F; Kane CT; Thiam S; Ndour CT; Gottlieb GS; Mboup S Int J STD AIDS; 2020 Oct; 31(11):1063-1072. PubMed ID: 32819210 [TBL] [Abstract][Full Text] [Related]
17. Comparing the impact of increasing condom use or HIV pre-exposure prophylaxis (PrEP) use among female sex workers. Mukandavire Z; Mitchell KM; Vickerman P Epidemics; 2016 Mar; 14():62-70. PubMed ID: 26972515 [TBL] [Abstract][Full Text] [Related]
18. A Review of Pre-Exposure Prophylaxis Adherence among Female Sex Workers. Ghayda RA; Hong SH; Yang JW; Jeong GH; Lee KH; Kronbichler A; Solmi M; Stubbs B; Koyanagi A; Jacob L; Oh H; Kim JY; Shin JI; Smith L Yonsei Med J; 2020 May; 61(5):349-358. PubMed ID: 32390358 [TBL] [Abstract][Full Text] [Related]
19. "I am still negative": Female sex workers' perspectives on uptake and use of daily pre-exposure prophylaxis for HIV prevention in South Africa. Eakle R; Bothma R; Bourne A; Gumede S; Motsosi K; Rees H PLoS One; 2019; 14(4):e0212271. PubMed ID: 30964874 [TBL] [Abstract][Full Text] [Related]
20. Factors Associated with Usage of Oral-PrEP among Female Sex Workers in Nairobi, Kenya, Assessed by Self-Report and a Point-of-Care Urine Tenofovir Immunoassay. Shah P; Spinelli M; Irungu E; Kabuti R; Ngurukiri P; Babu H; Kungu M; Champions TMFS; Nyabuto C; Mahero A; Devries K; Kyegombe N; Medley GF; Gafos M; Seeley J; Weiss HA; Kaul R; Gandhi M; Beattie TS; Kimani J AIDS Behav; 2024 Nov; 28(11):3836-3849. PubMed ID: 39136824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]